In particular, the presence of ILC2s significantly inhibited tumor formation in WT chimeric mice bearing tumors expressing IL-33, when compared to RORa−/− chimeras, suggesting the role of IL-33/ILC2s axis in mediating the anti-tumor immunity. The gene discussed is IL33; the disease is neoplasm.